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Abstract
Emergence agitation (EA) is common among pediatric patients undergoing general
anesthesia. Sevoflurane is a volatile anesthetic that is associated with an increased
incidence of EA of as high as 80% in children undergoing surgery. Emergence agitation
can cause increased stress in the patient, nurses and caregivers. Agitation experienced by
the patient can also increase the risk of self harm, delay medical treatments, damage
equipment and ultimately increase the length of stay in the hospital. Current studies lack
a consistent method of quantifying and recognizing EA in a standardized manner. The
development of the Pediatric Anesthesia Emergence Delirium (PAED) scale provided a
reliable and accurate tool to assess EA in pediatric patients. Propofol has been used in
sub-hypnotic doses to reduce both the incidence and severity of EA. The purpose of this
systematic review was to examine the current literature to determine if there is an effect
on PAED scores of patients that undergo general anesthesia with sevoflurane after
receiving an intravenous dose of propofol prior to emergence. This systematic review
was created using guidelines put forth by both PRISMA and CONSORT. A literature
review was performed and data were collected from each study. A cross study analysis
was performed using data collection tables created by the author of this systematic
review. Propofol was found to decrease both the incidence and severity of EA in
pediatric patients undergoing ophthalmic, inguinal hernia repair, adenostonsillectomies
and non-painful procedures such as MRI scans. By incorporating the use of propofol in
the anesthetic plan for pediatric patients, anesthesia providers will be able to decrease the
incidence the EA and its’ associated adverse outcomes.
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Propofol And Emergence Agitation In The Pediatric Population: A Systematic Review
Background/Statement of the Problem
Approximately four million children undergo general anesthesia each year in the
United States (Miller et al., 2015). One of the most common inhalation anesthetic agents
used in pediatric general anesthesia is sevoflurane. Sevoflurane is a volatile anesthetic
that allows for a rapid induction as well as timely emergence related to its low blood gas
coefficient. It is these same reasons that may also make sevoflurane one of the leading
causes of emergence agitation in the pediatric population. Sevoflurane has been
associated with an incidence rate of emergence agitation as high as 80% in children
(Kim, Yoon, Lim & Yoon, 2011).
Emergence agitation (EA) can occur after general anesthesia and includes
behaviors such as crying, disorientation, excitement and delirium (Miller et al., 2015).
These children can suffer from paranoid delusions and display restlessness that can
quickly escalate to combative behavior (Vlajkovic & Sindjelic, 2007). Although the
condition is self-limiting, the increased risk of patient injury and stress experienced by
both the patient and their care giver(s) have made the limitation of EA a focus of research
(Kim, Moon, Kim & Lee, 2012). These patients are also at a greater risk of disrupting
medical treatments and equipment, requiring extra nursing care and ultimately requiring a
longer length of stay (Vlajkovic & Sindjelic, 2007).
There are many tools available for both the reporting and rating of EA. Due to
the questionable validity and reliability of the tools that were presently available, the
pediatric anesthesia emergence delirium scale (PAED) was developed (Sikich & Lerman,
2004). The scale consists of five scale items by which the patient is evaluated. These
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items include; eye contact, purposeful actions, awareness of surroundings, restlessness
and consolability (Sikich & Lerman) (Figure 1).

Figure 1. PAED scoring tool
Each item is scored numerically between 1 and 4 and the sums of the individual
scores comprise the total PAED score. The degree of emergence agitation is directly
correlated with increasing scores. “A score of >4 (from crying and difficult to console to
wild thrashing) for a five or more minute duration despite active calming efforts is
regarded as indicative of emergence delirium” (Reduque & Verghese, 2012, p.1). The
internal consistency of the scoring tool was 0.89 along with a reliability rating of 0.84
(95% confidence interval, 0.76-0.90) (Sikich & Lerman, 2004). The authors developed
three hypotheses to further validate the PAED scale. The first hypothesis was supported,
with the scores having a negative correlation with the age of the patient (r =-0.31,
P<0.04). The second hypothesis also showed a negative correlation with the score but in
relation to the awakening time (r=-0.5, P <0.001). The PAED scores were found to be
higher after the administration of sevoflurane compared to that of halothane (P <0.008)
with a sensitivity of 0.64 (Sikich & Lerman).
Many medications have been used prophylactically to decrease the incidence of
EA including fentanyl, ketamine, midazolam and most recently dexmedetomidine
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(Precedex). Propofol has also been used as an adjunct medication for the prevention of
EA. Propofol is a hypnotic sedative that achieves its anesthetic effect by inhibiting
GABA receptors in the central nervous system (Nagelhout & Plaus, 2014). It is often
used as an induction agent for pediatric anesthesia when given intravenously at a dose of
2-3 mg/kg (Nagelhout & Plaus). Propofol used at sub-hypnotic doses (1 mg/kg) at the
end of general anesthesia has been found to decrease the incidence of EA when
sevoflurane was used as the primary inhalation anesthetic (Messieha, 2013).
The purpose of this paper was to present a systematic review conducted to
determine if the administration of propofol decreases the incidence of EA as evidenced
by decreased PAED scores after the use of sevoflurane during general anesthesia in the
pediatric population.
Next, the review of the literature will be presented.
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Literature Review
Emergence agitation is a global phenomenon within the pediatric patient
population. Key, Rich, DeCristofaro and Colllins (2010) conducted a literature review
with the goal of evaluating the incidence of EA in children that were administered
anesthesia in three categories: sevoflurane alone, propofol as an adjunct to sevoflurane
and propofol used as a total intravenous anesthesia technique. The literature review
examined a total of 10 randomized control trials. Three trials used sevoflurane as the sole
anesthetic, five used propofol for total intravenous anesthesia and the final two studies
used propofol as an adjunct anesthetic at the end of the surgery. A total of 1172 children
aged 1- 6 years old were included in the studies. A higher incidence of EA within the
sevoflurane only studies was reported as compared to those patients that received
propofol either at the end of the surgery or as part of a total intravenous anesthetic.
Children that underwent procedures were found to have EA rates ranging from 50-60%
when sevoflurane was given as the sole anesthetic agent. Emergence agitation incidence
rates dropped to 4.8% - 19% and 3.7% - 11% with the propofol adjunct and TIVA groups
respectively.
Although the literature review conducted by Key et al. (2010) could demonstrate
a direct correlation between the administration of propofol and the decreased incidence of
EA, there were many limitations that affected the overall strength of the findings. One of
the key discrepancies occurring throughout the review is the lack of a consistent
measurement tool of emergence agitation. Some studies used a four-point scale; others
used the PAED tool while others were not specified. This lack of consistency can affect
the validity of the review. The information lacking in this particular literature review
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inspired the problem statement for this systematic review by limiting the EA tool to
include only the PAED scale.
Studies Using the PAED Scale to Measure EA in Pediatric Subjects
Inguinal hernia repair. There were several randomized control trials that utilized
the PAED as their primary tool for measuring pediatric emergence delirium. One such
trial compared the administration of both propofol and fentanyl in the effective
prevention of EA related to sevoflurane anesthesia (Kim et al., 2012). This randomized
double blinded control trial involved 205 children aged 18 -72 months of age. All of the
children were scheduled to undergo an inguinal hernia repair and were considered in
good health with ASA ratings of no greater than II. Each of the participants were
randomly assigned to either the propofol group (group P: n = 69), the fentanyl group
(group F: n = 66), or the placebo group, which received saline (group S: n = 70). At the
completion of the surgery, each participant received the dosing of assigned medication:
propofol dosed at 1mg/kg; fentanyl dosed at 1µg/kg; and 2ml of saline. Upon arrival to
the post-anesthesia care unit (PACU) the PAED scale was used every five minutes for the
first 30 minutes after arrival on the unit. The mean PAED score was 4.3 for group P and
4.9 in group F (P = 0.682), which were lower than the mean of 9.0 in group S (P <
0.001). This trial demonstrated a significant decrease in the PAED score for the pediatric
patients that received a sub-hypnotic dose of both the propofol and fentanyl. Limitations
of the study include the lack of variety of procedures performed which decreases the
generalizability of the results of the study. All of the patients underwent an inguinal
hernia repair. “Emergence agitation is different depending on the type of surgery and is
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known to be higher in otorhinolaryngological or ophthalmological procedures” (Kim et
al., p.279).
Opthalmic procedures. Strabismus correction is a commonly performed
ophthalmologic surgical procedure in the pediatric population. Aouad et al. (2007)
performed a randomized double-blind study that aimed to determine if a single dose of
propofol given at the end of sevoflurane anesthesia would decrease the incidence of EA
after strabismus surgery. Eighty children aged 2-6 years that were scheduled for elective
strabismus surgery were selected for the study. Children were randomly assigned to the
propofol group (n = 41) and the saline placebo group (n = 39). The propofol group
received 1mg/kg at the end of surgery where as the placebo group received an equal
volume of saline.
The PAED scores were obtained and the mean scores of the propofol group (8.6 +
3.9; P = 0.004) were much lower than the saline group (11.5 + 4.5; P = 0.004). The
scores were generally higher in relation to those obtained during the trial involving the
inguinal hernia procedures, but still demonstrated a reduction in the appearance and
severity of EA. Limitations of this study involved the use of the PAED tool. One of the
evaluation items included making eye contact with the caregiver that would have been
hard to determine with unilateral ocular dressings.
Although not as common as strabismus surgery, cataract surgery is also
performed in the pediatric population. A study conducted by Chen, Li, Hu & Wang
(2010) set forth to determine if the use of sub-hypnotic doses of propofol, ketamine or
midazolam would decrease the incidence of EA after cataract surgery performed under a
sevoflurane anesthetic using the PAED tool. A total of 120 children aged 1-7 were
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selected to participate. All of the patients were scheduled for an elective cataract removal
procedure and were randomly assigned to one of three postoperative groups (n = 40):
midazolam (MF) group, propofol (PF) group and the ketamine (KF) group. At the end of
the procedure, as the sevoflurane was being discontinued the patients received a dose of
medications based on which group they were assigned to. The MF group received
0.05mg/kg of midazolam, the PF group received 1 mg/ kg of propofol and the KF group
received 0.25 mg/kg of ketamine. The patients were then evaluated for EA in the PACU
at 5,10, 15 and 30-minute intervals using the PAED assessment tool. The peak scores
were recorded and a value of > 10 was considered indicative of EA.
The number of patients with a PAED score >10 in the KF group were 18 (45%)
and the number of patients that had scores > 15 were 10 (25%). The MF and PF group
demonstrated a much lower percentages of PAED scores > 10 with only 15% (P =
0.0034) and 20% (P = 0.017) respectively. The PAED scores that were >15 within the
MF group were only 2.5% (P = 0.0035) and the PF group had only 7.5% (P = 0.0339) of
the patients with an elevated score.
Although this study illustrates a clear reduction in the PAED score in those
patients that received a sub-hypnotic dose of propofol, there were also limitations. The
lack of a placebo group weakens the study design. The author stated that the decision to
not include a placebo group was based on ethical reasons and considerations (Chen et
al.).
Adenotonsillectomy procedures. Adenotonsillectomy procedures are commonly
performed in the pediatric population. A randomized control trial conducted by Lee et al.
(2010) set forth to determine if a single dose of propofol given at the end of anesthesia
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would decrease the incidence and severity of EA when sevoflurane was administered.
Ninety children between the ages of 3-8 years were selected to participate in the study.
All of the participants were scheduled for an elective adenotonsillectomy and were
randomly assigned into two groups. One group received propofol at1 mg/kg (n = 45) and
the other group received saline at 0.1ml/kg (n = 45) at the end of the surgery. Emergence
delirium and agitation was then measured using the PAED scale at 5 (T5), 15 (T15) and
30 (T30) minute intervals after emergence.
The incidence of EA in the propofol group was lower when compared to the
saline group at the T5, T15 and T30 marks. The mean scores of the PAED scale at T5,
T15 and T30 were 12.6 + 4.6, 8.2 + 3.8, and 5.0 + 3.1 respectively in the propofol group
while 13.8 + 4.7, 8.0 + 3.9 and 4.5 + 3.1 in the saline group. Although there was not a
significant reduction in the incidence or severity of EA at the T5 or T15 time marks, the
effectiveness was more clearly demonstrated at T30. The authors did not recommend the
administration of propofol after adenotonsillectomy surgery and stated that further studies
were needed in order to better differentiate between post-operative pain and agitation
(Lee et al.).
Another study conducted by Ali & Abdellatif (2013) also focused on the
prevention of sevoflurane related EA in children undergoing adenotonsillectomy and the
effectiveness of propofol and dexmedetomidine as preventative medications. A total of
120 children aged 2-6 years old were selected that had been scheduled for an elective
adenotonsillectomy. The patients were randomly assigned to one of three groups: those
that received 10ml of 0.9% normal saline (Group C, n = 40); those that received 1mg/kg
propofol (Group P, n = 40); and those that received 0.3µg/kg of dexmedetomidine (Group
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D, n = 40). All of the study groups received their doses of medication five minutes prior
to the conclusion of the procedure. The PAED scores were assessed at 5 (T5), 10(T10)
and 15(T15) minute intervals. The incidence of EA within Groups P and D were lower
compared to that of Group C. At T5, Group C (saline) had a mean PAED score of 8.4 +
4.5, Group P (propofol) had a mean score of 6.6 + 3.2, and Group D (dexmedetomidine)
had a mean score of 5.2 + 2.9. Compared to group D, the incidence and severity of EA in
group P were significantly higher at T0, T5, and T15 but not T 30. This trial
demonstrated that although propofol reduces the overall PAED scores when compared to
a placebo, it also has a higher incidence of EA when compared to other adjuvants such as
dexmedetomidine. The effectiveness of propofol didn’t exceed that of dexmedetomidine
until 30 minutes after the emergence from anesthesia.
Non-painful procedures. The previous trials all include surgical procedures that
are both stimulating and associated with a significant amount of post surgical pain. One
randomized control trial that was conducted by Abu-Shahwan (2008) focused on the
effects of propofol on EA after the administration of sevoflurane anesthesia for nonpainful procedures. 84 children between the ages of 2-7 years old were selected for the
study. The patients were all scheduled to undergo a magnetic resonance imaging (MRI)
study that required general anesthesia. No surgical interventions were necessary and there
were no expectations of peri- or post-procedure pain. The patients were randomly
assigned to either group P which received 1mg/kg propofol prior to emergence or group S
which received only a placebo dose of saline. The PAED scoring system was used
during the first 30 minutes after emergence for each of the groups. The peak PAED
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scores for the propofol group was 7 compared to the peak score of 13 of the saline group.
Both the groups’ peak PAED scores were associated with a P value <0.05.
A more recent randomized control trial conducted by Costi et al. (2015) involved
pediatric patients scheduled to complete MRI procedures under general anesthesia. A
total of 230 children aged from 1 to 12 years old where randomly assigned to either
receive a propofol bolus of 3mg/kg over 3 minutes or no intervention at the end of
general anesthesia comprised of inhaled sevoflurane. The group receiving the propofol
bolus had a decreased incidence of EA as well lower PAED scores. The percentage of
patients presenting with EA in the propofol group, compared to that of the placebo group
were 7% and 29 % respectively with a confidence interval of 0.12-0.52 and P < 0.001.
Although this study did not use a sub-hypnotic dose of propofol, the administration of
3mg/kg over a period of three minutes had a significant effect on the incidence of EA
based on PAED scores. This trial was included as a discussion point for the need for
further research regarding the range of dosages and the concurrent effects on EA.
In summary, the administration of propofol prior to emergence from sevoflurane
anesthesia decreased the PAED scores in all of the randomized control trials reviewed.
Next, the theoretical framework utilized for this systematic review will be discussed.
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Theoretical Framework
The emphasis on evidence based practice and its influence on the development of
new clinical guidelines have made systematic reviews and meta-analyses the cornerstone
of present day healthcare. Systematic reviews can provide the basis for changes in the
delivery of care and therefore the strength and validity of their content must be
scrutinized. The preferred reporting items for systematic reviews and meta-analyses
(PRISMA) statement was used to guide the creation of this systematic review (Moher,
Liberati, Tetzlaff & Altman, 2009). The PRISMA guidelines were created in order to not
only improve the quality of review reporting, but also to assist in the assessment of a
systematic review’s strengths and weaknesses. Both the PRISMA checklist and flow
diagram were used to insure the creation of a strong and relevant systematic review.
The PRISMA checklist (Appendix A) contains 27 evidence-based items that were
used in developing and reporting this systematic review (Moher et al., 2009). These items
included factors such as title, abstract, introduction, methods, data collection processes,
synthesis of results, bias reporting and limitations. While creating this systematic review
the author referred to the checklist and insured that all items were addressed within the
report.
The PRISMA tool also includes a flow diagram, illustrated on the following page
(Figure 2), that assisted in the process and organization of the literature review. The flow
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Identification

PRISMA 2009 Flow Diagram

Records identified through
database searching
(n = )

Additional records identified
through other sources
(n = )

Eligibility

Screening

Records after duplicates removed
(n = )

Records screened
(n = )

Records excluded
(n = )

Full-text articles assessed
for eligibility
(n = )

Full-text articles excluded,
with reasons
(n = )

Included

Studies included in
qualitative synthesis
(n = )

Studies included in
quantitative synthesis
(meta-analysis)
(n = )

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and MetaAnalyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097

For more information,
www.prisma-statement.org.
Figure 2. PRISMA Flowchart (Moher
et al., visit
2009)
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chart organized the search results based on both inclusion and exclusion criteria
determined by the author of the review. The end result provided a final number of
studies that were included in the systematic review. The PRISMA guidelines provided a
framework in which the author could create a relevant and strong systematic review.
In addition to the PRISMA checklist and flowchart, the author also utilized the
consolidated standards of reporting trials framework (CONSORT, 2010) (Appendix B)
checklist to further evaluate and insure the quality of the randomized control trials that
were reported. The CONSORT checklist was designed to specifically examine
randomized control trials and evaluate their strengths, weaknesses and limitations. It is
also utilized to identify sources of bias. This checklist was used for the critical appraisal
for each of the articles used for the creation of this systematic review. There are 25 items
on the checklist including items such as trial design, eligibility of participants, sample
size determination, randomization methods, blinding, limitations, statistical methods and
generalizability.
All of the randomized clinical control trials included within this systematic review
were also evaluated across the studies. The PAED scores, emergence times, discharge
times and adverse effects were compared among the control and interventional groups
within the seven trials. This information was recorded within a data collection table
created by the author of this review to compare the effects of propofol on these outcomes.
Next, the methods section will be presented and discussed.
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Method
Purpose
The purpose of this paper was to present a systematic review conducted to
determine if the administration of propofol decreases the incidence of EA as evidenced
by decreased PAED scores after the use of sevoflurane during general anesthesia in the
pediatric population.
Inclusion/Exclusion Criteria
Inclusion criteria consisted of randomized clinical trials, meta-analyses or
systematic reviews conducting in the last 10 years that included the following: pediatric
surgical population (ages six months to 18 years); elective surgical procedures; use of
sevoflurane for general anesthesia, use of PAED as assessment tool for measuring
emergence agitation, ASA I -III; and propofol given at or near the end of the procedure
(within 15 minutes).
Exclusion criteria included: use of alternate tools for assessment of EA; studies
conducted in foreign languages; literature over 10 years old; ASA IV patients or
emergent cases; adult patients; use of isoflurane or desflurane; conscious or moderate
sedation; propofol given at the beginning of the procedure or over 30 minutes prior to the
conclusion of surgery; and studies that consisted of less than 20 subjects.
Search Strategy
The literature search was performed using both the Pubmed and Medline
databases. An initial generalized search was conducted by using the keyword “Propofol”
within each database. A total of 2730 articles were located within Pubmed and an
additional 17,308 articles were available through Medline. The search was narrowed by
the addition of a second keyword “Emergence Agitation”. The results from both Pubmed
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and Medline were drastically reduced to 56 and 54 items respectively. A final filter was
placed on the search limiting the publication of the literature between the years of 2005
and 2015, as well as restricting the results to those articles that focused on human
subjects only, were written in English and published in peer reviewed journals. The final
search yielded 38 articles from Pubmed and 30 articles from Medline.
Data Collection
The randomized control trials (RCT) were reviewed and relevant data collected
for further analysis. In an effort to analyze the influence of not only propofol on PAED
scores, but also other variables presented within the randomized control trials, two tables
were created for data collection and comparisons across studies.
The first table was designed to record basic information about the randomized
control trials including author, year of study, number of patients included in the study,
ages of participants, gender, ASA score, procedure performed, procedure duration and
allocation of participants into control and interventional groups (Table 1).
Table 1
Data Collection Sheet #1
Author,Year

# Pt in
Trial

Ages
(yr)

M/F

ASA

Procedure

Duration
(min)

Propofol
Group

Interventional
Group

A second table was designed to collect data on other variables that may have
influenced PAED scores within the trials including interventional dose and timing of the
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administration, timing of obtainment of PAED scores, parental presence, timing of
emergence and discharge from PACU as well as any adverse events (Appendix C).
Critical Appraisal
The CONSORT method (Appendix B) was used to critically appraise the
randomized control trials included within this systematic review. The 25-item checklist
was used to identify strengths, weaknesses, biases and limitations of each of the trials.
The items include identification of trial design, eligibility and selection of participants,
settings, sample size, interventions, randomization methods, limitations and funding.
A flow diagram designed by CONSORT, illustrated in Figure 3 on the next page,
was utilized to further assess and determine the overall strength and weaknesses of the
randomized control trials. The diagram focuses on the sample size, randomization,
allocation of participants and those participants that may have been lost during follow up
and analysis. A flow diagram was completed for each randomized control trial used for
this systematic review
A table was created in order to facilitate the collection and organization of data
concerning the strengths, methods of sampling, randomization, funding and limitations of
each randomized clinical trial (Appendix D). These were constructed through the
information obtained by utilizing both the PRISMA and CONSORT checklists and flow
diagrams. This method provided a more succinct and valuable assessment tool.
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CONSORT 2010 Flow Diagram

Enrollment

Assessed for eligibility (n= )

Excluded (n= )
¨ Not meeting inclusion criteria (n= )
¨ Declined to participate (n= )
¨ Other reasons (n= )

Randomized (n= )

Allocation
Allocated to intervention (n= )
¨ Received allocated intervention (n= )

Allocated to intervention (n= )
¨ Received allocated intervention (n= )

¨

¨

Did not receive allocated intervention (give
reasons) (n= )

Did not receive allocated intervention (give
reasons) (n= )

Follow-Up
Lost to follow-up (give reasons) (n= )

Lost to follow-up (give reasons) (n= )

Discontinued intervention (give reasons) (n= )

Discontinued intervention (give reasons) (n= )

Analysis
Analysed (n= )
¨ Excluded from analysis (give reasons) (n= )

Figure 3. CONSORT Flow Diagram (CONSORT, 20

Analysed (n= )
¨ Excluded from analysis (give reasons) (n= )
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Data Synthesis & Cross Study Analysis
The data collection tools created to extract information from the randomized
control trials were utilized in both synthesizing the data and analyzing the data across the
studies. A cross study analysis was performed that evaluated the effects of propofol on
overall PAED scores, emergence times, discharge times and the development of any
adverse events that occurred during the study. The data were entered in the table
depicted below (Table 2) and the results will be described later in this paper.
Table 2
Cross Study Analysis
Author, Year
Type of
Procedure

Propofol Group
–affect on
PAED scores

Propofol Group
Affect on
Emergence Times

Next, the results section will be discussed.

Propofol Group
Affect on
Discharge Time

Adverse
Events
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Results
The PRISMA flowchart (Appendix E), along with the inclusion and exclusion
criteria previously mentioned, were used to further eliminate and select articles that were
appropriate for the systematic review. There were several duplicate articles found within
both the databases, and after their elimination, a total of 32 articles remained for review.
The abstracts of these articles were reviewed for evidence of exclusion criteria that would
deem them not appropriate for the systematic review. This process eliminated a total of
10 articles. The remaining 22 articles were reviewed in their entirety for relevance and
selected for the systematic review based on both the exclusion and inclusion criteria.
This final elimination process omitted 14 articles from the search results, leaving a total
of 8 articles for inclusion within the systematic review.
Of the eight articles that remained, seven were randomized control trials with only
one literature review that was relevant to the purpose of this systematic review. The
seven randomized control trials met the inclusion criteria and were used in the creation of
this systematic review. The following is a summary of results obtained from the data
collection sheets. The results are organized per similar procedures performed as
previously categorized in the literature review section.
Non-Painful Procedures
The randomized control trial conducted by Abu-Shahwan (2008) (Appendix F1a, 2a) included 83 pediatric patients ranging from 2-7 years old with a 1:1 male to
female ratio. Patients underwent outpatient MRI procedures and all had ASA scores
below 2. The mean duration of the procedures was 73 minutes. The patients were
induced using a mask inhalation method utilizing a combination of sevoflurane and

20

nitrous oxide. A laryngeal mask airway with pressure support ventilation was used during
the procedure. Anesthesia was maintained using 2% sevoflurane and a mixture of 60%
nitrous oxide and 40% oxygen mixture. At the completion of the procedure the propofol
group (n = 42) received 1mg/kg of propofol intravenously and the saline group (n = 41)
received 0.9% normal saline in an unspecified amount. The LMA was removed once
regular respirations were obtained and before the patient fully emerged from the
anesthetic. Emergence occurred in the post recovery area with parents present at the
discretion of a recovery nurse. There was no additional data provided indicating the
percentage of patients with parents present at emergence. The degree of agitation was
measured using the PAED scoring system upon awakening and then every 5 minutes
during the first 30 minutes after admission to the recovery area. The peak PAED score
was recorded for evaluation. The propofol group had a peak PAED score of 7 (P < 0.05),
where as the saline group had a peak score of 13 (P < 0.05). There were no adverse
physiologic events noted for either group of patients. Emergence (eye opening) times for
the propofol and saline groups were 9 + 3.4 minutes and 7 + 2.7 minutes respectively.
The time to discharge for the propofol group was 31.21 + 6.1 minutes and the saline
group required 33.4 + 5.8 minutes before being discharged from the recovery area.
The study conducted by Abu-Shahwan (Appendix F-3a) was able to collect
significant data, despite a small sample size, with PAED scores that were obtained with a
P value of <0.05. The PAED scores were further compared between the groups using the
Mann-Whitney U-test and Fisher’s exact test. Although the results are generalizable to a
vast majority of pediatric patients, the lack of specified timing of interventions and data
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concerning the initial assessment and recruitment of patients weakened the results of the
study.
Using the CONSORT framework, a flow diagram was constructed that assessed
the sample size, eligibility, exclusion criteria, randomization and attrition of the
participants within the study (Appendix G-1). There was a substantial amount of data not
reported within the study. Data including initial sample size, number of patients
excluded prior to randomization and the associated rationale were not available. There
was just one exclusion reported of a patient within the control group who had received
propofol during the study.
Costi et al. (2015) (Appendix F-1b, 2b) also conducted a randomized control trial
focusing on pediatric patients undergoing MRI procedures. The study included 218
patients ranging from the ages of 1 -12 years of age. All the participants were an ASA 2
or less. 109 participants were randomly assigned to a control group and the remaining
One hundred and nine participants were administered 3 mg/kg of propofol at the
completion of the MRI. Oral midazolam (0.5 mg/kg) was administered pre-operatively
and the patient was either induced with sevoflurane and oxygen or with propofol
intravenously. An LMA was placed and anesthesia maintained with an unspecified
concentration of sevoflurane and nitrous oxide. The PAED scores were obtained upon
arrival to the PACU and at 5-minute intervals for the first 30 minutes. Peak PAED scores
and ranges for each group were reported. The control group had a peak PAED score of
10 (P < 0.001) with a range of 6-13. The group that received propofol had a peak PAED
score of 6 (P < 0.001) with a range of 2-10. The average emergence times of the propofol
and control group were 17 + 10 minutes and 9 + 10 minutes respectively (P < 0.001).
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The average discharge time from the PACU was 95 + 38 minutes for the propofol group
and 99 + 48 minutes for the control group (P = 0.573). Whether there was parental
presence during recovery was not specified. Laryngospasm was noted in three patients in
the control group and only one patient from the propofol group. No other adverse events
were reported.
There were both strengths and weaknesses noted within the study conducted by
Costi (Appendix F-3b). The study reported data that included significantly reduced
PAED scores within the propofol group with a P value of <0.001. These data were
further analyzed using the Shapiro-Wilks test. Limitations of this trial include
administration of a higher dose of propofol (3mg/kg) than that of the other trials within
this systematic review, as well as some participants being administered propofol upon
induction despite being part of the control group.
The study conducted by Costi (Appendix G-2) reported their participant selection
and allocation using the CONSORT flow diagram. Twelve participants were excluded
from the initial selection due to refusal to participate. A large sample size consisting of
230 participants completed the study and were included in the final analysis.
Adenotonsillectomy procedures
The trial conducted by Ali and Abedellatif (2013) (Appendix F-1c, 2c) compared
the effects of dexmedetomidine and propofol on the severity of EA within a pediatric
population undergoing adenotonsillectomy procedures. The study included 120 patients
with ages ranging from 2-6 years old. There were 69 males and 51 females that
completed the trial, all of which had an ASA score of 2 or less. The procedures had a
mean duration of 58 minutes. The patients were administered oral midazolam (0.5mg/kg)
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pre-operatively. General anesthesia was induced with mask inhalation with sevoflurane
and nitrous oxide. Endotracheal intubation was performed with the aid of rocuronium
(0.6mg/kg) and general anesthesia was maintained with sevoflurane (2-3%) combined
with a 60% concentration of nitrous oxide and 40% oxygen mixture. Antiemetic
medications including dexamethasone and paracetamol were administered
perioperatively. Reversal with atropine and neostigmine was utilized prior to extubation.
Five minutes before the conclusion of the surgery 40 patients were administered 1 mg/kg
propofol intravenously. A control group consisting of 40 patients was given
10ml of normal saline and the remaining 40 patients received 0.3mg/kg of
dexmedetomidine. Each intervention was administered over a period of five minutes.
PAED scores were obtained at four different time intervals; upon arrival to the recovery
areas and then at five, 15 and 30 minute intervals.
The saline group had the overall highest PAED scores with an average of 13.7 +
at the time of the arrival to the recovery room, and 7 patients had PAED scores greater
than 15. Those patients that received propofol prior to emergence had an average PAED
score of 11.6 + 3.8 and only two patients with PAED scores greater than 15. The
precedex group had the lowest PAED scores with an average of 9.8 + 3.5 upon arrival to
the PACU with only two patients with PAED scores greater than 15. All participants had
parental presence once arriving to PACU. The emergence times were the greatest among
the propofol group at 12.3 minutes compared to the saline and precedex groups at 10.7
minutes and 10.9 minutes respectively. Discharge from the PACU times were the
greatest among the precedex groups at 40.1 minutes, followed by the propofol group at
38.5 minutes and the saline group which averaged a time of 10.7 minutes. Vomiting
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occurring in five patients receiving propofol, four that received precedex and three that
were part of the saline interventional group. No other adverse events were noted.
The trial conducted by Ali and Abedellatif (Appendix F-3c) reported a significant
decrease in the PAED scores of both those participants that received propofol and in
those that received precedex. Both results were reported with a P value of <0.05. The
larger sample size and the frequency of the procedure performed in the pediatric
population strengthened the data collected for this systematic review. Other than the lack
of information concerning the initial participant selection and exclusion data, this study
had very few limitations.
Using the CONSORT framework a flow diagram was constructed in an attempt to
assess the sample size, eligibility, exclusion criteria, randomization and attrition of the
participants within the study (Appendix G-3). The data within the study were not
specific concerning the original numbers of participants the sample was selected from nor
were specific reasons for exclusions of the participants after the randomization was
performed provided.
Another randomized control trail focusing on the effects of propofol on PAED
scores within a pediatric population undergoing an adenotonsillectomy procedure was
conducted by Lee et al. (2010) (Appendix F-1d, 2d). This study included 88 patients
ranging in age from 3- 8 years old. All participants had an ASA score of 1. Patients
were randomly assigned to either receive propofol or to a control group receiving saline.
Patients received 1mg/kg of intravenous thiopental pre-operatively. Anesthesia was then
induced with an additional 5mg/kg of thiopental and 0.5 mg/kg of atracurium. An
orotracheal intubation was performed and general anesthesia was maintained with
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sevoflurane at 2-2.5% combined with a 50% nitrous oxide and oxygen mixture. Either 1
mg/kg of propofol or 0.1 ml/kg of saline was administered at the completion of the
procedure after the inhalation agents were discontinued. The PAED scores were obtained
at five, 15 and 30 minute intervals after arrival to the PACU. The average PAED scores
for the propofol group were 12.6 at five minutes, 8.2 at 15 minutes and 5.0 at the thirtyminute recording. PAED scores for the saline group were increased at all three intervals
with scores of 13.8, 8.0 and 4.5 respectively. One patient from the trial had a parent
present in the PACU. Emergence times averaged 13.7 minutes for the propofol group
and 12.2 minutes for the saline group. Average time of discharge from the PACU was
24.2 minutes within the propofol group and 25 minutes for the saline group. Nausea and
vomiting were reported in four of the propofol patients and six of those that received
saline. No other adverse effects were reported.
Although this study showed a decrease in PAED scores within the propofol group
there were significant limitations. The sample size was small and with P values between
0.655 and 0.815 (Appendix F-3d), the results lacked significance. The painful nature of
the procedure made it difficult to determine whether the behaviors exhibited by the
patient were related to post-operative pain or EA.
The study conducted by Lee et al. (Appendix G-4) reported participant selection,
randomization and attrition using the CONSORT flow diagram. Although the number of
patients within the initial pool of participants was not specified, a total of 13 patients
were lost after randomization. Five patients from the propofol group did not receive the
intervention related to severe agitation at induction, laryngospasm or an inadequate
caudal block. Eight patients from the control groups were eliminated for the same
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reasons. The data obtained from a patient within the propofol group was omitted related
to ST depressions during the procedure. A patient from the control group was also not
included within the final analysis related to excessive surgical bleeding.
Opthalmic procedures
The randomized control trial performed by Aouad et al. (2007) (Appendix F-1e,
2e) involved 77 pediatric patients ranging in age from two to six years old. The patients
underwent either bilateral strabismus surgery (n = 23) or unilateral strabismus surgery (n
= 18). All the participants had an ASA of 2 or lower. The mean duration of the
procedures was 39 minutes. Patients received oral midazolam (0.5mg/kg) 30 minutes
prior to arrival to the operating room. Mask inhalation induction was performed with
sevoflurane and nitrous oxide and an LMA was implemented to maintain the airway.
General anesthesia was maintained with 2-3% sevoflurane along with a 60% nitrous
oxide and 40% oxygen mixture. Antiemetic medications including paracetamol and
dexamethasone were given peri-operatively. At the completion of the procedure and
once the inhaled anesthetics were discontinued, the propofol group received 1 mg/kg of
propofol and the control group received an equivalent volume of saline. The PAED
scores were obtained upon removal of the LMA and in unspecified time intervals until
the patient was deemed calm. The overall mean PAED score for the propofol group was
8.6 + 3.9 compared to that of the saline group 11.5 + 4.5. There were differences among
the patients that underwent unilateral versus bilateral procedures. The patients that
received propofol had a mean PAED score of 8.3 + 2.7 while undergoing a unilateral
procedure, whereas the patients that underwent bilateral procedures had a mean PAED
score of 8.9 + 4.7. The saline group also experienced an increase of PAED scores among
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those that underwent a bilateral procedure. Recipients of the saline intervention during a
unilateral procedure had a mean PAED score of 10 + 4. Those that underwent a bilateral
procedure had an increased mean PAED score of 13.2 + 4.5. Emergence times among
the propofol group were slightly increased at 23.4 + 5.7 minutes compared to 19.7 + 5
minutes experienced by the patients administered saline. All patients within this study
had parental presence during the post recovery stage. Discharge times from the PACU
were not adversely affected by the administration of propofol compared to that of those
that received saline. The propofol group was discharged in an average of 34.1 + 8.4
minutes whereas the saline group averaged 34.9 + 8.6 minutes. Parents were present with
all participants during the recovery stage and no adverse events were reported.
This study involved a procedure that has a high incidence of EA, making it a very
relevant study to include in this systematic review (Appendix F-3e). A decrease in
PAED scores was demonstrated within the propofol group with a P value = .004.
Although a significant correlation was reported, PAED scoring was more difficult within
this patient population. Forty-four patients within the propofol group had a unilateral
procedure done, where as the remaining 56 patients had a bilateral procedure performed.
There were 58 patients that received unilateral treatment and 42 patients that underwent
bilateral procedures within the saline group. One of the items within the PAED scoring
system is for the child to make eye contact with the assessor. Due to the nature of this
procedure and the location of bandages and protective eye wear, the PAED scores within
this study may have been affected.
A CONSORT flow diagram was created to collect data regarding the selection
and analysis of the participants (Appendix G-5). The study did not include information
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about the initial pool of participants nor detailed information about the one patient from
the control group that was excluded from the final analysis.
Chen et al. (2010) (Appendix F-1f, 2f) conducted a randomized control trial
involving 120 pediatric patients undergoing cataract surgery. Laterality of the procedure
was not specified. The participants were aged from one to seven years old and all had
ASA scores of 2 or less. Average surgical time was 32 minutes. No medications were
administered preoperatively and anesthesia was induced with sevoflurane and oxygen
through mask inhalation. Remifentanil (0.15 mcg/kg/min) was administered
intravenously, along with a one-time dose of atropine (0.01 mg/kg). An LMA was placed
and general anesthesia was maintained with 1.5-2% sevoflurane and oxygen. The
remifentanil infusion was titrated to maintain ventilation (.05 – 0.25 mcg/kg/min).
Patients were randomly assigned to one of three groups (n=40). Once the procedure was
finished, children in the propofol group were administered 1mg/kg of propofol combined
with 0.5 mcg/kg of fentanyl. The ketamine group received 0.5 mcg/kg of ketamine
combined with 0.5 mcg/kg of fentanyl, and the midazolam group received 0.05 mg/kg
midazolam combined with 0.5 mcg/kg of fentanyl. The PAED scores were recorded
upon arrival at PACU and at five, 10, 15 and 30-minute intervals. The number of
patients with PAED scores higher than 10 and 15 were also recorded. The mean PAED
score of the propofol group was 6, with a score range of 3 to 15. A total of eight patients
had PAED scores equal or higher than 10, and an additional three patients scored a 15 or
higher. The ketamine group had a mean PAED score of 9 with a scores ranging from 310. Eighteen patients had a PAED score equal or greater than 10, and ten patients scored
higher than 15. Patients in the midazolam group had a mean PAED score of 5 with a
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range of 2-15. Six patients had PAED scores greater than or equal to 10, and only one
patient had a score greater than 15. Average emergence time for those patients in the
propofol group was 17.0 + 2.1 minutes. The midazolam and ketamine groups had
average emergence times of 21.2 + 3.5 minutes and 19.4 + 5.2 minutes respectively.
Average time to discharge for the propofol group was 27.3 + 4.9 minutes, where as the
midazolam group experienced an average of 29.3 + 6.2 minutes and the ketamine group
averaged 30.4 + 3.3 minutes. Parental presence during recovery was not specified. The
ketamine group had two patients with hallucinations and nightmares. No other adverse
reactions were reported.
The study conducted by Chen et al. (Appendix F-3f) had also demonstrated a
significant decrease in PAED scores within the propofol group with a P value of <0.05.
Limitations of this study included the lack of a placebo group as well as fentanyl being
administered as part the interventions. As with the previous study involving ocular
procedures, visual acuity is affected and may make PAED scoring difficult in the post
operative period.
A CONSORT flow diagram was created for this study to collect the data reported
concerning the sample selection, allocation and attrition rates (Appendix G-6). The study
did not provide information regarding the initial patient pool from which their
participants were selected. There were no participants lost to follow up or analysis after
the initial selection and randomization into treatment groups.
Inguinal hernia procedures
Kim et al. (2012) (Appendix F-1g, 2g) compared the use of fentanyl and propofol
for the prevention of EA in pediatric patients undergoing inguinal hernia repair. All
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patients were an ASA 2 or below. A total of 205 patients ranging in age from one to six
years old were randomly assigned to three groups. A control group was administered an
unspecified amount of saline at the completion of surgery. Patients within the
interventional groups received wither 1 mg/kg of propofol or 1 mcg/kg of fentanyl. All
patients received a caudal block with 0.5% bupivacaine (1.2 ml/kg) after a mask
inhalation induction with 8% sevoflurane and placement of an LMA. Anesthesia was
maintained with sevoflurane 2-2.5% with a 50% oxygen flow. No pre-medications were
administered. PAED scores were obtained upon the arrival to PACU and at five minute
intervals for the first 30 minutes. The average score was then reported for each group.
The propofol group had a mean PAED score of 4.3, compared to 9.0 and 4.9 of the saline
and fentanyl group respectively. The average emergence time of the propofol group was
27.7 minutes compared to the 17.6 minutes of the saline group and 17.6 minutes of the
fentanyl group. Discharge from PACU took an average of 37.1 minutes for the propofol
group and 33.4 minutes for the saline group. The fentanyl group was the most delayed
with an average time of 40.4 minutes. There were no parents present in the PACU during
this trial. Airway obstruction was noted in two patients within the propofol group and
four that received fentanyl. Laryngospasm was reported in one patient in both the
propofol and fentanyl groups. Nausea and vomiting was present in four of the propofol
patients, two of the saline participants and 17 of those patients that received fentanyl. No
other adverse reactions were reported.
This study had the advantage of a large sample size and reported a significant
correlation between the administration of propofol and decreased PAED scores with a P
value of <0.001 (Appendix F-3g). The use of a caudal block deemed this a relatively
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painless procedure, eliminating the chance of post operative pain being assessed as EA.
Limitations of this study included the elimination of patients that showed anxiety preoperatively which is considered a contributing factor to EA. Inguinal hernia repair has a
low incidence of EA making the results of the study less generalizable to other pediatric
surgical procedures.
The CONSORT flow diagram was used in the study to report data related to
sample selection, allocation and attrition (Appendix G-7). Of the original 265 patients
assessed for the study, 43 were excluded related either not meeting inclusion criteria or
declining to participate. Of the patients that were selected and randomized into
interventional groups, 17 were not included in the study due to either extreme agitation
during induction, laryngospasm or inadequate caudal blocks.
Cross Study Analysis
The randomized control trials used for this systematic review were analyzed
across studies utilizing the data collection sheet previously depicted in Table 2. This tool
was used to record and analyze the PAED scores, emergence times, discharge times and
adverse effects amongst the propofol and control groups for each review (Appendix H).
All the randomized control trials included within this systematic review reported a
decrease in PAED scores for children who received propofol prior to emergence after
receiving a sevoflurane based general anesthetic (Appendix H-1, 2, 3, 4, 5, 6, 7). The
most profound decreases were found within the studies involving non-painful procedures
such as outpatient MRI procedures. The study conducted by Abu-Shahwan (Appendix
H-1) reported a peak PAED score of seven (P < 0.05) within the propofol group
compared to that of 13 (P < 0.05) of the control group. Costi (Appendix H-2) reported a
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peak PAED score of six (P < 0.001) within the propofol group compared to a peak score
of 10 within the control group.
The seven studies also did not report a significant change in either the average
emergence times nor the time of discharge from the post recovery area between the
propofol and control groups (Appendix H). Five studies reported increased emergence
times for the propofol groups ranging from 1.5 to 10 minutes (Appendix H-1, 2, 4, 5, 7).
One study reported a decrease in emergence time of 1.6 minutes (Appendix H-3),
whereas the remaining study did not contain a control group for which a comparison
could be made (Appendix H-6). Discharge times were increased from between 0.6 to 3.7
minutes in two of the studies included within this review (Appendix H-3, 7). Four trials
reported an overall decrease in discharge times ranging from 0.8 to 4 minutes (Appendix
H-1, 2, 4, 5). One trial did not contain a control group for which a comparison could be
made (Appendix H-6).
There were few adverse effects reported within the propofol groups of the studies
included with this systematic review. Three studies reported no adverse effects for both
the control and interventional groups (Appendix H-1, 5, 6). Nausea and vomiting was
reported in three studies (Appendix H-3, 4, 7) and was the most common adverse event
within the propofol groups. Laryngospasm was the second most common adverse effect
and was reported within two of the studies for the children that received propofol
(Appendix H-2, 7).
Next, summary and conclusions section will be presented.
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Summary and Conclusions
Emergence agitation among pediatric patients undergoing general anesthesia is a
disruptive phenomenon. Children that experience EA are at a greater risk of self-injury,
interruption of medical treatment, increased stress upon caregivers and longer lengths of
stays (Vlajkovic & Sindjelic, 2007). Sevoflurane has been associated with an increased
rate of EA in as high as 80% of children undergoing procedures under general anesthesia
(Kim et al., 2011). A literature review was conducted and found that although many
systematic reviews and meta-analyses existed, there was a lack of a single consistent
method of detecting and quantifying EA. The PAED scale is a five-item tool designed to
quantify emergence agitation in the pediatric patient (Sikich & Lerman, 2004). This scale
was developed to provide a consistent and reliable tool in which EA can be measured. It
is for this reason the author chose studies that incorporated this tool for the purpose of
evaluating EA in their patient populations. The purpose of this paper was to conduct a
systematic review to determine if the administration of a sub-hypnotic dose of propofol
would decrease the incidence and severity of the emergence agitation based upon PAED
scores in children undergoing general anesthesia with sevoflurane.
A literature review was conducted utilizing inclusion and exclusion criteria
created by the author. The PRISMA flowchart (Figure 2) was used to assist in the
organization and collection of data regarding the literature search. A total of eight
articles were selected, seven of which were randomized control trials. The randomized
control trials were subject to further critique using the CONSORT checklist (Appendix
B) in order to assure the strength and significance of the studies included within this
systematic review. Data were collected from the articles and recorded within tables
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created by the author (Appendix C). Information that was obtained from each study
included title, author, publication date, number of patients in trial, ages of participants,
gender, ASA score, procedure performed, duration of procedure, allocation of
participants to control and propofol groups, dose of propofol, intervention doses, timing
of administration, other medications given, PAED scores and times, parental presence,
emergence times, discharge times, airway interventions and any adverse events reported
(Appendix F-1,2). Strengths and weaknesses from each study were recorded within
another table created by the author of this review using the criteria listed within the
CONSORT checklist (Appendix F-3). The CONSORT flow diagram, which focuses on
the sample size, randomization and attrition rates of participants, was completed for each
randomized control trial (Appendix G – 1, 2, 3, 4, 5, 6, 7). Analysis across the studies
was performed utilizing the chart located in Appendix H. This chart recorded the PAED
scores, emergence times, discharge times and adverse effects of both the propofol and
control groups for all seven randomized control trials.
All seven of the randomized control trials used for this review reported a decrease
in PAED scores in patients that received at least 1 mg/kg of intravenous propofol prior to
emergence (Appendix H-1, 2, 3, 4, 5, 6, 7). The most profound decreases in PAED
scores were found within the studies that did not involve painful procedures such as
undergoing an MRI as an outpatient (Appendix H-1, 2). The patients in the Costi et al.
study (Appendix H-2) received a higher dose of propofol than the other six studies;
3mg/kg versus 1mg/kg. This increased dose may have affected the PAED scores. AbuShahwan (Appendix F-2a) also looked at the effects of propofol on PAED scores among
pediatric patients undergoing MRI and utilized the sub-hypnotic dose of propofol (1
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mg/kg). Pain can affect the ability to distinguish EA from delirious behavior associated
with noxious stimuli, which can have a significant affect on the ability to accurately
assess PAED scores. Examination of the PAED scores of patients undergoing painless
procedures helped to validate the effect of propofol on EA.
Procedures that are associated with more intraoperative and postoperative pain
also showed a decrease in PAED scores when a sub-hypnotic dose of propofol was
administered prior to emergence. Pediatric patients undergoing adenotonsillectomy
procedures were studied by Ali (Appendix H-3) and Lee (Appendix H-4). The study
conducted by Lee reported decreased initial average PAED scores within the propofol
group (12.6) as compared to that of the saline group (13.8). Decreased PAED scores
were also recorded in the Ali study with the propofol group having an initial average
PAED score of 11.6 compared to that of the saline group, which averaged a score of 13.7.
A third interventional group received dexmedetomidine and had an even lower reported
average PAED score of 9.8. Adenotonsillectomies are a more painful procedure than that
of an MRI and a patient’s response to pain may be misread as EA. It may be for these
reasons that the overall PAED scores are higher than those in the studies involving the
MRI and the differences between the saline group and propofol group less significant.
The use of precedex provided the lowest severity of EA and could be attributed to its
analgesic effects for which propofol lacks.
All seven of the studies did not report a significant increase in either the average
emergence times nor the time of discharge from the post recovery area between the
propofol and control groups (Appendix H-1, 2, 3, 4, 5, 6, 7). The propofol groups had
emergence times between 2 and 6 minutes longer than the control groups in six of the
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studies (Appendix H-1, 2, 4, 5, 7). The study conducted by Kim et al (Appendix H-7)
had an emergence time among the propofol group that was 10 minutes longer than the
control group. This may have been attributed to the analgesic effects of the caudal block
administered prior to the procedure. Discharge from the post recovery area was also not
greatly affected by the administration of propofol prior to emergence. In two of the
studies the discharge time increased by 0.6 to 4 minutes (Appendix H-3, 7). Four studies
(Appendix H-1, 2, 4, 5) showed a decrease in discharge times within the propofol group
when compared to those patients within the control group. The one study that lacked a
control group had a discharge of time of 27.3 + 4.9 minutes (Appendix H-6).
Adverse effects were reported in four of the seven randomized control trials
(Appendix H-2, 3, 4, 7). Laryngospasms, airway obstruction, and post-operative nausea
and vomiting (PONV) were the most commonly reported events. The patients with
reported episodes of PONV within the propofol groups (Appendix H-3, 4, 7) were within
studies that included procedures with an existing higher incidence of PONV such as
strabismus surgery and adenotonsillectomy procedures (Appendix H-4, 5).
Although diversity amongst the procedures performed provided stronger evidence
for this systematic review, the differences amongst the timing and recording of PAED
scores potentially weakened the conclusions that can be drawn from the data synthesis.
The PAED scores were recorded at various time intervals, and in the case of the study
conducted by Aouad (Appendix F-2e) time intervals were not accurately described.
Studies differed on their reporting of PAED scores by the means of average scores, peak
scores, ranges and number of patients that achieved scores higher than 10 or 15. A
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consistent scoring timeline and recording algorithm would have provided stronger
evidence of the effect of propofol on the reduction of PAED scores.
There were limitations of this systematic review process. Though the studies
included in this review met the inclusion criteria, which were identified as reasonable, the
inclusion of seven randomized control trials with relatively small sample sizes overall
may lessen the generalizability to the pediatric surgical population at large. This review
may have benefitted from selecting trials of subjects undergoing identical surgical
procedures. Variables such as pain and body systems affected would not have been able
to potentially affect the PAED scores. Non-painful procedures, such as outpatient MRI
studies and inguinal hernia repairs performed under a caudal block (Appendix F-2a, 2b,
2g) were stronger studies related to eliminating the risk of interpreting the patients’
response to pain as EA. In contrast, adenotonsillectomy procedures (Appendix F-2c, 2d),
which are associated with more discomfort post-operatively, had higher PAED scores
than that of the MRI studies (Appendix F-2a, 2b, 2c, 2d). These higher PAED scores
may not have been a direct reflection of EA, but rather of the misinterpretation of the
child’s response to pain. Studies that included patients undergoing ophthalmic
procedures (Appendix F-2e, 2f) were at risk for obtaining weakened results related to the
inability to assess accurate PAED scores. One of the items on the PAED scoring system
included making eye contact with the assessor (Figure 1). Due to decreased visual acuity
related to the procedure itself and subsequent bandages and protective eye wear required
post operatively, the inability to assess this portion of the PAED scoring system may
have affected the strength of the results.
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Despite these limitations, this systematic review provides sufficient evidence to
implicate propofol as an effective means to reduce EA in the pediatric patient population.
Recommendations and implications for advanced nursing practice will be discussed in
the next section.
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Recommendations and Implications for Advanced Nursing Practice
Certified Registered Nurse Anesthetists (CRNAs) are Advanced Practice
Registered Nurses (APRNs) that rely on evidence-based research daily. Systematic
reviews provide the tools and evidence required in order to provide safe anesthesia.
CRNAs are responsible for the peri-operative care of the pediatric patient. CRNAs
provide safe and uneventful emergency and recovery of the pediatric patient until the
intraoperative report is conveyed to the Post Anesthesia Recovery Unit (PACU) nurse.
Emergence agitation during emergence with the use of sevoflurane in the pediatric
population makes waking increasingly unpredictable for the CRNA and operating room
staff.
The administration of anesthesia is a combination of both a science and an art.
Competence is achieved through education, clinical practice and developing a safe and
effective technique of administering personalized and appropriate anesthesia. Continuing
education is crucial to both the education of the anesthesia provider and the safety of their
patients. Systematic reviews such as the one created by this author are intended to
provide up to date information regarding the latest, safest and most effective methods of
providing anesthesia across the lifespan. This information can be used not only to
improve the practice of existing practitioners, but also become incorporated in the
curriculum of institutions training future CRNAs.
The use of propofol prior to emergence has been shown to decrease the PAED
scores in children undergoing a variety of procedures in this systematic review. Not only
have the PAED scores been lowered, but also the overall emergence times and discharge
from hospital times were minimally effected. Many practitioners are hesitant in

40

administering propofol prior to emergence and extubation related to an increased risk of
adverse effects such as airway obstruction and subsequent laryngospasm. As the data
within Appendix H shows, there were minimal events within the propofol group and no
significant differences between those receiving either a control or alternate intervention.
Propofol in sub-hypnotic doses is considered an anti-emetic within itself and can actually
decrease the incidence of PONV (Miller, 2015).
Emergence agitation episodes can not only cause stress and increase the potential
for injury for the patient, but it can also increase the stress and decrease the satisfaction of
the caregiver/parent. In the ever-changing field of health care, there has been a focus on
patient satisfaction and most recently this has affected the reimbursement protocols for
many Medicare and Medicaid patients. If patients are dissatisfied with their care,
including pain control and overall experience, the hospital may not be paid the full
reimbursement allocated for the procedure. Although pediatric patients often do not
receive care from either the Medicare or Medicaid agencies, caution must be exercised if
the trend continues in the future, other insurance plans and healthcare programs may
follow suit and a wider population of patients may be affected. Creation of policies that
direct the CRNA to provide prophylactic measures to decrease the incidence and severity
of EA may become commonplace as this emphasis on patient satisfaction continues.
This systematic review may also be the backboard to many future research
endeavors. Propofol was shown to decrease the incidence and severity of EA in the
pediatric population, but as the study conducted by Ali (Appendix F-2c) reported,
dexmedetomidine had an even greater effect on lowering PAED scores. Future studies
may be performed comparing dexmedetomidine and propofol and their effects on EA.
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There are many other surgical and procedural factors that may be examined in relation to
their effects on EA as a result of this systematic review. Numerous variables could be
further researched including surgical duration, patient gender and parental presence to see
if they have an overall effect on PAED scores. These studies would be essential in
developing even safer and more effective anesthetic protocols in the pediatric surgical
population.
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Appendix B

(CONSORT, 2010)
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Appendix C
Data Collection Sheet #2
Author,
Year

Propofol
Dose

Intervention
Doses

Time of
Intervention

Anesthestics,
Analgesia &
other meds

PAED
Propofol
Group

PAED
Interventional/
Control Group

PAED
scoring
&
timing

Parental
presence

Emergence
time

Discharge
Time

Airway

Adverse
Effects
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Appendix D
Randomized Control Trial Appraisal Chart

Author, Year

Study Type

Consent/Funding

Inclusion
Criteria

Exclusion
Criteria

Randomization

Attrition

Blinding

Strengths

Limitations
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Appendix E

Identification

PRISMA FLOW DIAGRAM

Records identified through
PUBMED search
(n = 38 )

Records identified through
MEDLINE search
(n = 30 )

Included

Eligibility

Screening

Records after duplicates removed
(n = 32 )

Records screened
(n = 32 )

Records excluded
(n = 10 )

Full-text articles assessed
for eligibility
(n = 22 )

Full-text articles excluded,
with reasons
(n = 14 )

Studies included in
qualitative synthesis
(n = 8 )

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta(Moher et
al.
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097

For more information, visit www.prisma-statement.org.
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Appendix F-1

Data Collection Sheet #1
Author, Year

# Patients
in Trial

Ages (yr)

M/F

ASA

Procedures

Duration
(min)

Propofol
Group

Interventional
Group

a

Abu-Shahwan,
2008

83

2-7

42/41

>2

Outpatient MRI

73

n = 42

Saline = 41

b

Costi, 2015

218

1-12

119/99

<2

Outpatient MRI

64

n = 109

No intervention = 109

c

Ali, 2013

120

2-6

69/51

<2

Adenotonsillectomy

58

n = 40

Saline =40
Precedex = 40

d

Lee, 2010

88

3-8

51/37

<2

Adenotonsillectomy

43

n = 44

Saline = 44

e

Auoad, 2007

77

2-6

40/37

<2

Strabismus

39

f

Chen, 2010

120

1-7

49/71

<2

Cataract

32

g

Kim, 2012

205

1-6

138/67

<2

Inguinal hernia

62

n = 41
unilateral = 18
bilateral = 23
n = 40
(w/ fentanyl)
n = 69

Saline =36
unilateral = 20
bilateral = 16
Ket/Fent = 40
Midaz/Fent = 40
Fentanyl = 66
Saline = 70
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Appendix F-2
Data Collection Sheet #2

a

b

c

Author,
Year

Propofo
l Dose

Intervention
Doses

Time of
Intervention

AbuShahwan,
2008

1 mg/kg

Saline-no
dose
specified

End of
procedure
after d/c of
sevo and
N2O, before
LMA
removal (no
exact time
specified)
completion of
MRI and d/c
of sevo

Costi

Ali, 2013

3 mg/kg

1 mg/kg

no
interventional group

Saline 10ml
Precedex 0.3
mcg/kg

5 min before
end of
surgery

Anesthetics,
Analgesia &
other meds
60% N20
2% Sevo

PAED
propofol

PAED
intervent

7 (P<0.05)

Saline = 13
(P<0.05

PAED
scoring &
timing
awakening,
q 5 min for
1st 30 min.
Peak scores
recorded

Parental
Presence
some
parents
were
present,
no exact
%

Emerge
Time
(min)
Propofo
l=9+
3.4
Saline =
7 + 2.7

D/C
Time

Airway

Adverse
Effects

Prop =
31.21 +
6.1
Saline =
33.4 +
5.8

LMA

none

LMA

Laryngospasm
occurred in
3 from
control and
1 in
propofol
groups
vomit in
propofol
group (5),
saline (3)
precedex
(4)

P=ns
P=ns
N2O – conc.
not specified
Sevo- conc.
not specified

60% N2O
2-3% Sevo
Midazolam
Paracetamol
Decadron
Rocuronium
Neostigmine
Atropine

peak = 6
range = 210

peak =10
range =613

P<0.001

P<0.001

T0=11.6
T5=6.6
T15=5.7
T30=4.1
>15=3
P<0.05

Saline
T0=13.7
T5=8.4
T15=5.7
T30=4.2
>15=7
Precedex
T0=9.8
T5=5.2
T15=4.2

arrival to
PACU and
5 min
intervals
for 1st 30
min. Peak
and range
recorded
arrival to
PACU(T0),
5,15,30
min
intervals.
total # of
pts with
PAED >15
recorded
for each

not
specified

100% of
patients
with
parents
present

Prop =
17 + 10
Control
9 + 10

Prop=
95 + 38
Control
99 + 48

P<0.001

P<0.001

Prop=
12.3
Saline=
10.7
Precede
x
10.9

Prop=
38.5
Saline=
37.9
Precede
x
40.1

P<0.05

P<0.05

ETT

52

T30=3.5
>15=2

d

e

f

Lee, 2010

Auoad,
2007

Chen,
2010

1 mg/kg

1 mg/kg

1 mg/kg
w/
fentanyl
0.5
mcg/kg

Saline
0.1mg/kg

Saline –
equal to
volume of
propofol

midazolam –
0.05mg/kg
w/fentanyl
0.5 mcg/kg
Ketamine
0.25 mg/kg
w/fentanyl
0.5 mcg/kg

completion of
procedure
after d/c of
inhalation
agents

N2O 50%
Sevo 2-2.5%
Thiopental
Atracurium
Ketorolac

completion of
surgical
procedure
after d/c of
inhalation
agents

60% N2O
2-3% Sevo
Midazolam
Lidocaine
Paracetamol
Decadron

completion of
procedure
prior to d/c of
inhalation
agents and
after d/c of
remi

fentanyl
remifentanil
atropine
TIVA

T5= 12.6
T15= 8.2
T30= 5.0

P<0.05
T5= 13.8
T15= 8.0
T30= 4.5

P = 0.60.8
Overall
mean =
8.6 + 3.9
Unilat =
8.3 + 2.7
Bilat =
8.9 + 4.7

P= 0.6-0.8

P=0.004

P=0.004

mean 6
range 310
PAED>10
=8
> 10 =8
> 15 =3

Midaz
mean 5
range 2-15
>10 = 6
>15 =1
Ketam
mean 9
range 3-20
> 10 =18
> 15 =10

P<0.05

Overall
mean=
11.5 + 4.5
Unilat =
10 + 4
Bilat =
13.2 + 4.5

P<0.05

group

5, 15 and
30 min
after arrival
to PACU

1 patient
had
parental
presence

prop=
13.7
saline=
12.2

prop=
24.2
saline=
25

ETT

@LMA
removal
cont.
PAED
recording,
highest
score used

100%
patient
with
parents
present

Prop =
23.4 +
5.7
Saline =
19.7 +
5

Prop=
34.1 +
8.4
Saline =
34.9 +
8.6

LMA

P=0.004

P=0.68

Prop =
17.0 +
2.1
Midaz =
21.2 +
3.5
Ketami
ne
19.4 +
5.2

Prop =
27.3 +
4.9
Midaz =
29.3 +
6.2
Ketami
ne
30.4 +
3.3

arrival @
PACU, 5,
10,15 & 30
min. Mean
PAED
scores
recorded.
Also # of
pts with
scores > 10
and 15

not
specified

LMA

N/V
prop (4)
saline (6)

none

ketamine
group = 2
patient with
hallucinations and
night
terrors
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g

Kim, 2012

1 mg/kg

saline –
unspecified
amount
fentanyl1mcg/kg

completion of
surgery after
d/c of sevo

Caudal
block with
0.5%
bupivacaine
Sevo 2-2.5%

mean =
4.3

saline =9
fent =4.9

P<0.001

P<0.001

arrival to
PACU and
5 min
intervals
for 1st 30
min, mean
scores
evaluated

no
parents
present

Prop =
27.7
Saline =
17.6
Fentany
l
17.6

Prop=
37.1
Saline=
33.4
Fentany
l
40.4

P<0.001

P<0.001

LMA

airway
obstruct:
prop (2)
saline (0)
fent (4)
Laryngospasm:
prop (1)
saline (0)
fent (1)
N/V:
prop (4)
saline (2)
fent (17)
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Appendix F-3
Randomized Control Trial Appraisals

a

Author,
Year

Study Type

Consent/
Funding

Inclusion
Criteria

Exclusion
Criteria

Randomizatio
n

Attrition

Blinding

Strengths

Limitations

AbuShahwan
, 2008

Prospective
Randomized
Double
Blinded

ethics
committee
approval
and parental
consent

ASA I-II,
2-7 yo,
elective
MRI as
outpatient
with GA,
normal
cognitive
function

patients were
excluded
based on
cognitive
disorders,
developmenta
l delay and
the need for
sedatives
prior to
induction

randomized
into two
treatment
groups using
random
number
generator

1 patient lost
related to
administration
of propofol to
placebo group

interventional and
placebo
administered
by
anesthesia
assistant,
EA
evaluated by
blinded
recovery RN

Generalizable MRI is a non
painful
procedure and
study was able
to exclude pain
as contributing
factor to EA

PAED
scoring
difficult in
pediatric eye
surgery r/t
inability to
make eye
contact,
increased
difficulty
with bilateral
procedures

no funding
indicated

double blinded
P<0.05, U-test,
fisher’s exact
test
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b

Costi,
2015

Prospective
Randomized
Double
Blinded
Control
Trial

ethics
committee
approval &
registered
with
Austrailian
and NZ
clinical trial
registry,
informed
parental
consent

ASA I-II,
age 1-12,
undergoing
MRI under
GA

performance
of painful
procedure,
pupillary
dilation,
allergy to
propofol or
eggs, family
history of MH

randomly
assigned to
control or
interventional
group by
computer
generated
numbers

Ali, 2013

Prospective
Randomized
Double
Blinded

IRB
approval
and written
consent
from parents
no funding
indicated

outcome
assessor was
blinded to
intervention

12 initially
lost for
refusal to
participate

ASA I-II,
2-6 yo,
elective
adenotonsillectomy

excluded
mental
disease, neuro
disease and
treatment with
sedatives, full
stomach or
need for RSI

randomized
into 3 groups
using
computerized
generated
randomization
table

all patients
that were
enrolled
completed the
study

large patient
sample
provides
insight on EA
in patients
undergoing
non-painful
procedures
double blinded

no
participants
lost after
randomization
and allocation

Fundingsociety for
paediatric
anaesthesia
in New
Zealand and
Austrailia

c

use of
CONSORT
flow diagram
to report
sample
selection

use of
CONSORT
flow diagram
P<0.001 for
PAED scores

IV meds
prepared
and hidden
behind
drapes.
Anesthesia
provider
administered
meds, 2nd
blinded
provider
assessed
PAED

Data check
with Shapiro
wilks test
T&A surgery
commonly
performed in
pediatric
population.
Demonstrated
decreased
PAED scores
among
propofol and
precedex
groups
double blinded

some
patients were
administered
propofol at
induction
higher
propofol
dose of
3mg/kg
administered
P=0.573 for
hospital
discharge
time –
weakened
signficance

CONSORT
not used in
study –
unclear
original
participant
selection and
attrition
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d

Lee,
2010

Prospective
Randomized
Double
Blinded
Control
Trial

IRB
approval
and written
parental
consent

ASA I, 3-8
yo, elective
adenotonsi
-llectomy

mental
disease,neuro
disease,
sedative
medication
usage

no funding
indicated

e

Auoad,
2007

Prospective
Randomized
Double
Blinded
Control
Trial

IRB
approval
and written
parental
consent
no funding
indicated

ASA I-II,
2-6 yo,
elective
strabismus
surgery
under GA

Mental
disease, neuro
disease,
sedatives, full
stomach, RSI

randomly
assigned to
one of two
groups by
computer
generated
numbers

randomly
assigned into
propofol or
control group
using
computer
generated
numbers

1 patient from
propofol
group
dropped r/t
ST depression
on EKG, 1
patient from
saline group
related to
bleeding on
extubation

3 patients
were excluded
from saline
group r/t
incomplete
data
collection

blinded
anesthesia
provider
assessed
PAED
scores postoperatively

anesthesia
provider that
collected
data was
blinded to
which
intervention
was
administered

double blinded
procedure with
high incidence
of EA

difficulty
determining
if pain or
delirium
no
significant
decrease in
EA within
propofol
group

Generalizabilit
y - eye
surgeries
common with
pediatric
population,
increased risk
of PONV and
EA
P=.004

small sample
PAED
scoring
difficult in
pediatric eye
surgery r/t
inability to
make eye
contact,
increased
difficulty
with bilateral
procedures

double blinded
CONSORT
flow diagram
not used – no
specific
reporting of
participant
selection and
attrition
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f

Chen,
2010

Prospective
Randomized
Double
Blinded
Control
Trial

ethics
committee
approval
and parental
consent

ASA I-II,
1-7 yo,
elective
cataract
surgery

behavioral
problems &
physical
developmenta
l delay

no funding
indicated

randomly
assigned to
one of three
groups by
means of
computer
generated
numbers

no patients
were lost after
initial
enrollment

blinded
recovery
nurse
assessed
PAED
scores

double blinded
minimal pain
involved in
procedure –
eliminate pain
as cause of EA
P<0.05 on
PAED scores

lack of
placebo
group
fentanyl
administered
to all patients
vision
affecting
PAED
assessment
no statistical
analysis of
emergence
times or
discharge
time

g

Kim,
2012

Prospective
Randomized
Double
Blinded
Control
Trial

IRB
approval
and national
registration
parental
consent
Funding by
departmenta
l monies

ASA I-II,
18-72
months,
elective
inguinal
hernia
surgery in
ambulatory
care setting

developmenta
l delay,
psychologic
or neurologic
disorders,
abnormal
airway,
reactive
airway
disease,
history of
general
anesthesia

randomly
assigned to
one of three
groups by
internet site
program

60 patients
were lost
during trial
related to
airway
complications
, severe
agitation at
induction and
failure to
receive
intervention

syringes
wrapped in
foil by
investigator
not involved
with
anesthesia,
assessors of
PAED
scores were
blinded

double blinded
non-painful
procedure

inguinal
hernia repair
has low
incidence of
EA
patients with
preoperative
anxiety
excluded –
contributor
to EA
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Appendix G-1

Abu-Shahwan, I. (2008). Effect of propofol on emergence behavior in children after
sevoflurane general anesthesia. Pediatric Anesthesia, 18, 55-59.

Enrollment

Assessed for eligibility
(n = 84)
Excluded (n =0 )
Not meeting inclusion criteria
(n =0)
Refused to participate
(n = 0)
Other reasons (n = 0)

Analysis

Follow up

Allocation

Randomized (n = 84)

Allocated to Propofol
Group
(n = 42)

Allocated to
Saline/Control Group
(n = 42)

Received allocated
intervention (n = 42)

Received allocated
intervention (n = 41)

Did not receive allocated
intervention (n = 0)

Did not receive allocated
intervention (n = 1)
patient received
propofol during procedure

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued intervention
(n = 0)

Discontinued intervention
(n = 0)

Analyzed (n = 42)

Analyzed (n = 41)

Excluded from analysis
(n = 0)

Excluded from analysis
(n = 1) – lost previously r/t
administration of propofol
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Appendix G-2

Costi, et al. (2015). Transition to propofol after sevoflurane anesthesia to prevent
emergence agitation: a randomized controlled trial. Pediatric Anesthesia, 5 (25),
517-523.

Enrollment

Assessed for eligibility
(n = 242)
Excluded (n = 12)
Refused to participate

Analysis

Follow up

Allocation

Randomized (n = 230)

Allocated to Propofol
Group
(n = 115)

Allocated to Control
Group
(n= 115)

Received allocated
intervention (n = 114)

Received allocated
intervention (n = 115)

Did not receive allocated
intervention (n = 1)
subcutaneous injection

Did not receive allocated
intervention (n = 0)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Analyzed (n = 109)

Analyzed (n = 109)

Excluded from analysis
laryngospasm (n=2)
protocol violation (n=1)
assessor unblinded (n =1)
missing data (n=1)

Excluded from analysis
laryngospasm (n=3)
protocol violation (n=1)
assessor unavail (n =1)
additional painful
procedure (n=1)
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Appendix G-3

Ali, M.A., & Abdellatif, A.A. (2013). Prevention of sevoflurane related emergence
agitation in children undergoing adenotonsillectomy: A comparison of
dexmedetomidine and propofol. Saudi Journal of Anaesthesia, 7 (3), 296-300.

Enrollment

Assessed for eligibility
(n = original numbers not
available)

Excluded
data not available

Randomized (n = 120)

Analysis

Follow up

Allocation

Allocated to Propofol
Group
(n = 40)
Received allocated
intervention (n = 40)
Did not receive allocated
intervention (n = 0)

Allocated to
Dexmedetomidine
Group
(n = 40)
Received allocated
intervention (n = 40)
Did not receive allocated
intervention (n = 0)

Allocated to
Saline/Control Group
(n = 40)
Received allocated
intervention (n = 40)
Did not receive allocated
intervention (n = 0)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Analyzed (n = 40)
Excluded from analysis
(n = 0)

Analyzed (n = 40)
Excluded from
analysis
(n = 0)
lr/administration of
propofol

Analyzed (n = 40)
Excluded from analysis
(n = 0)
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Appendix G-4
Lee, C.J. et al. (2010). The effect on propofol on emergence agitation in children
receiving sevoflurane for adenotonsillectomy. Korean Journal of
Anesthesiology, 2(52), 75-81.

Enrollment

Assessed for eligibility
not available
Excluded
data not available

Analysis

Follow up

Allocation

Randomized (n = 90)

Allocated to Propofol
Group
(n = 45)

Allocated to Control
Group
(n= 45)

Received allocated
intervention (n =69)

Received allocated
intervention (n = 66)

Did not receive allocated
intervention (n = 5)
severe agitation at
induction, laryngospasm,
inadequate caudal block

Did not receive allocated
intervention (n = 8)
severe agitation,
laryngospasm, inadequate
caudal block

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued
intervention (n = 1)
ST depression

Discontinued
intervention (n = 1)
surgical bleeding

Analyzed (n = 44)

Analyzed (n = 44)

Excluded from analysis
-see above

Excluded from analysis
- see above
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Appendix G-5

Aouad, M.D. et al (2007). A single dose of propofol at the end of surgery for the
prevention of emergence agitation in children undergoing strabismus surgery
during sevoflurane anesthesia. Anesthesiology, 107, 733-738

Enrollment

Assessed for eligibility
not available
Excluded

not available

Randomized (n = 80)

Analysis

Follow up

Allocation

Allocated to Propofol
Group
(n = 41)
Received allocated
intervention (n = 41)
Did not receive allocated
intervention (n = 0)

Allocated to
Saline/Control Group
Received allocated
intervention (n = 39)
Did not receive allocated
intervention (n = 0)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Analyzed (n = 41)

Analyzed (n = 36)

Excluded from analysis
(n = 0)

Excluded from
analysis
(n = 3)
excluded related to
incomplete data
collection
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Appendix G-6

Chen, J. et al. (2010). Emergence agitation after cataract surgery in children: a
comparison of midazolam, propofol and ketamine. Pediatric Anesthesia, 20,
873-879.

Enrollment

Assessed for eligibility
(n = 120)
Excluded (n =0 )
Not meeting inclusion criteria
(n =0)
Refused to participate
(n = 0)
Other reasons (n = 0)

Randomized (n = 120)

Analysis

Follow up

Allocation

Allocated to Propofol
Group
(n = 40)
Received allocated
intervention (n = 40)
Did not receive allocated
intervention (n = 0)

Allocated to Ketamine
Group

Allocated to Midazolam
Group

Received allocated
intervention (n = 40)

Received allocated
intervention (n = 40)

Did not receive allocated
intervention (n = 0)

Did not receive allocated
intervention (n = 0)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Analyzed (n = 40)

Analyzed (n = 40)

Excluded from analysis
(n = 0)

Excluded from
analysis
(n = 0)

Analyzed (n = 40)
Excluded from analysis
(n = 0)
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Appendix G-7

Kim, Y.H. et al. (2012). Prophylactic use of midazolam or propofol at the end of surgery
may reduce the incidence of emergence agitation after sevoflurane anaesthesia.
Anaesthesia and Intensive Care, 39(5), 904-908.

Enrollment

Assessed for eligibility
(n = 265)
Excluded (n = 43)
not meeting inclusion criteria
(n=31)
declined to participate (n=10)
other reasons (n=2)

Analysis

Follow up

Allocation

Randomized (n = 222)

Allocated to Propofol
Group
(n = 74)

Allocated to Fentanyl
Group
(n= 74)

Allocated to Control
Group
(n= 74)

Received allocated
intervention (n =69)

Received allocated
intervention (n = 66)

Received allocated
intervention (n = 70)

Did not receive allocated
intervention (n = 5)
severe agitation at
induction, laryngospasm,
inadequate caudal block

Did not receive allocated
intervention (n = 8)
severe agitation,
laryngospasm, inadequate
caudal block

Did not receive allocated
intervention (n = 4)
inadequate caudal block

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Discontinued
intervention (n = 0)

Analyzed (n = 69)

Analyzed (n = 66)

Analyzed (n = 70)

Excluded from analysis
(n=0)

Excluded from analysis
(n=0)

Excluded from analysis
(n=0)
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Appendix H
Cross Study Analysis

1

Author, Year
Type of Procedure

Propofol Group –affect on
PAED scores compared to
control

Propofol Group Affect on
Propofol Group Affect on
Emergence Times compared Discharge Time compared
to control (min)
to control (min)

Adverse Events in
Propofol group

Abu-Shahwan, 2008

Propofol = 7
Control = 13

Propofol = 9 + 3.4
Control = 7 + 2.7

Propofol = 31.21 + 6.1
Control = 33.4 + 5.8

none

(peak PAED)

P = ns

P= ns

P<0.05

increase of 2 min

decrease of 2.2 min

Propofol = 6
Control = 10

Propofol = 17 + 10
Control = 9 + 10

Propofol = 95 + 38
Control = 99 + 48

(Peak PAED scores)

P<0.001

P<0.001

P<0.001

increase by 8 min

decrease by 4 min

Outpatient MRI

decrease of 6

2

Costi, 2015
Outpatient MRI

decrease by 4

laryngospasm (n=1)
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3

Ali, 2013
Adenotonsillectomy

Propofol = 11.6, 6.6, 5.2,
4.1
Control = 13.7, 8.4, 5.7,
4.2

Propofol = 12.3 + 3.4
Control = 10.7 + 2.5

Propofol = 38.5 + 5.3
Control = 37.9 + 5.5

P<0.05

P<0.05

(PAED scores at T0,5,15
and 30)

decrease of 1.6 min

increase of 0.6 min

overall decrease at all time
intervals
Propofol = 12.6 , 8.2, 5.0
Control = 13.8, 8.0, 4.5

Propofol = 13.7 + 3.8
Control = 12.2 + 4.1

Propofol = 24.2 + 5.0
Control = 25.0 + 6.1

(score at 5,15 and 30 min)

P = 0.188

P = 0.516

P value range from 0.6550.672

increase by 1.5 min

decrease by 0.8 min

Propofol = 23.4 + 5.7
Control = 19.7 + 5

Propofol = 34.1 + 8.4
Control = 35.9 + 8.6

P=0.004

P=0.68

vomiting (n=5)

P<0.05

4

Lee, 2010

nausea and
vomiting (n=4)

Adenotonsillectomy

overall decrease in PAED
scores except at 15 min
mark
5

Auoad, 2007
Strabismus

Propofol = 8.6 + 3.9
Control = 11.5 + 4.5
(mean PAED)
P=0.004
decrease of 2.9

increased emergence time of decreased discharge time of
3.7 min
1.8 min

none
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6

Chen, 2010

Propofol = 6

Propofol = 17.0 + 2.1

Propofol = 27.3 + 4.9

Cataract

(score in PACU)

No Control group

No Control group

No Control group

No statistical analysis other
than SD

No statistical analysis other
than SD

Propofol = 4.3
Control = 9

Propofol= 27.7
Control = 17.6

Propofol = 37.1
Control = 33.4

(mean PAED score)

P<0.001

P<0.001

P<0.001

increase by 10.1 min

increase by 3.7 min

none

P< 0.05

7

Kim, 2012
Inguinal Hernia

decrease by 4.7

airway obstruction
(n=2)
laryngospasm (n=1)
nausea/vomiting
(n=2)

